Off-Label Drug Use and Fda Review of Supplemental Drug Applications

Whilst the greatest effort has been made to ensure the quality of this text, due to the historical nature of this content, in some rare cases there may be minor issues with legibility. Pervasive off-label use can blur the distinction between medical information and drug promotion, as pharmaceutical developers, with neither financial nor regulatory incentives to undertake costly supplemental studie...